Articles tagged with Gastrointestinal Disorders
Consuming insects like crickets can contribute to healthy gut microbiota and provide essential nutrients. Research by CSU professor Tiffany Weir and colleagues highlights the potential benefits of edible insects on human health, including increased prebiotic effects and reduced intestinal inflammation.
Researchers propose a new method of clustering colorectal cancer patients using differential presence of exons (DPE) sequencing, which can provide valuable information on CRC progression and response to therapy. This analysis may also reduce costs and time required for staging CRC patients.
A UC Riverside-led study found that reduced PTPN2 activity in intestinal epithelial cells leads to decreased Paneth cell antimicrobial peptide production, disrupting the gut microbiota and increasing E. coli. This loss can serve as a marker of IBD disease.
A new study by Oxford researchers has found vedolizumab to be effective in inducing remission in patients with chronic pouchitis after surgery for ulcerative colitis. The treatment improved remission rates and quality of life, making it a game-changer for these patients.
Researchers analyzed DNA from Beethoven's hair to shed light on his chronic health problems, including progressive hearing loss. They found genetic risk factors for liver disease and evidence of a hepatitis B virus infection, which likely contributed to his death.
A study published in Gut journal found that COVID-19 patients experienced gastrointestinal symptoms more frequently than non-infected patients. The research also discovered a higher incidence of irritable bowel syndrome among infected individuals, with symptoms lasting up to 12 months after hospitalization.
An international team of researchers has received $3 million to study how early gut development shapes children's health. They will collect tissue samples from diverse groups to understand the impact of environment, genetics, and other factors on gut development.
A recent study found that Black infants in the US were disproportionately affected by necrotizing enterocolitis, with higher mortality rates compared to White infants. Despite overall improvements in NEC-related deaths between 1999 and 2020, racial disparities persisted.
The American Foregut Society has proposed a new classification system to assess esophagogastric junction (EGJ) integrity, expanding beyond the Hill grade. The new classification takes into account EGJ disruption and hiatus hernia extent, providing a more comprehensive understanding of GERD.
Researchers developed a platform for localizing and tracking wireless microdevices in the GI tract, achieving millimeter-scale spatial resolution. The system has potential to revolutionize clinical diagnosis and treatment of GI disorders without invasive procedures or radiation exposure.
A new dietary approach has been identified to treat eosinophilic esophagitis by eliminating only dairy products, showing similar effectiveness to the standard six-food elimination diet. This breakthrough study led by CU School of Medicine researchers offers a more patient-friendly treatment option with fewer drawbacks.
The BIAL Award in Biomedicine is a prestigious international award that recognises outstanding biomedical research. The €300,000 prize is given to researchers whose work has shown exceptional quality and scientific relevance, published within the last ten years.
Research highlights the need for holistic treatment of IBS patients' physical and mental tolls, including anxiety (38%) and depression (27%) rates significantly higher than in the general population. Early evaluation and treatment of both conditions is essential to improve patient quality of life.
Researchers have developed a novel prognostic index to predict survival outcomes in gastric cancer patients. The inflammation-combined prognostic index (ICPI) combines three biomarkers - lymphocyte-to-monocyte ratio, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio - to provide a personalized prognosis for each patient.
Researchers have created a tiny pill-like electromagnetic device that can provide medical professionals with diagnostic information about the inner workings of the gastrointestinal tract. The device, when swallowed, delivers data to a smartphone as it passes through the body using electromagnetic technology similar to MRI machines.
Researchers have developed a new system to facilitate the diagnosis and treatment of gastrointestinal motility disorders. The ingestible 'smart pill' tracks movement through the GI tract using magnetic fields, allowing for more accurate and efficient diagnosis and targeted therapeutic interventions.
Researchers explore CEACAM1, CEACAM5, and CEACAM6's pathological significance in cancer biology and immunology. The review highlights their interactions with pathogens and potential avenues for cancer therapy.
A team of researchers from MedUni Vienna has identified the polymeric immunoglobulin receptor (pIgR) as a key player in protecting against alcohol-induced liver damage. The study found that pIgR-mediated secretion of antibodies in the intestines helps to prevent bacterial translocation and inflammation in the liver.
Researchers have identified Piezo2, a receptor responsible for sensing touch and temperature, as the key player in gut pain. Selectively targeting this channel may lead to new treatments for irritable bowel syndrome and other gastrointestinal disorders.
Dupilumab, an FDA-approved medication, offers new hope for patients with eosinophilic esophagitis, a rising condition in the US. The treatment reduces eosinophil counts and improves symptoms of dysphagia, leading to better endoscopic healing and histologic severity improvements.
Researchers highlight recent progress in organotypic models, which offer a balance between the accessibility and control of in vitro context. These models have been used to study various aging-related phenotypes, including skin, gut, and skeletal muscle, providing valuable insights into the underlying mechanisms.
Salk scientists have developed a new therapeutic compound called FexD, which reverses gut inflammation in mouse models of inflammatory bowel disease. By activating the master regulator protein FXR, FexD reduces inflammation and restores balance to the digestive system.
Researchers at Karolinska Institutet have shown that B cells can prevent intestinal healing by increasing in numbers after bowel damage. The study found that mice lacking B cells recovered more quickly after bowel damage than regular mice.
A new deep learning model using conditional generative adversarial networks (cGANs) has been developed to diagnose bowel ischemia. The model achieved an accuracy of over 93% in segmenting ischemic intestine images, surpassing current subjective methods.
A new survey by the European Federation of Dietitians supports moderate coffee consumption as having clear health benefits, including improved alertness and sports performance. The study involved 585 dietitians from across 26 European countries.
A novel surgical procedure has shown promising results in addressing incontinence in children with Hirschsprung disease who underwent the pull-through operation. Four of six patients have achieved normal bowel function, reporting improved quality of life and increased freedom.
The study highlights the importance of the gut microbiome in metabolic conditions like obesity and neurological diseases such as Parkinson's. Pesticide exposure is also found to disrupt the gut microbiota, leading to brain-gut alterations that can exacerbate these conditions.
Researchers have developed a preclinical model of appendiceal cancer, which accurately recapitulates the disease's cell mix and behavior. The organotypic slice culture model offers promising new avenues for studying the pathobiology of this rare tumor and testing potential treatments.
Researchers discovered a link between reduced protein synthesis and Feingold syndrome type 1, a rare genetic disorder. The study suggests that a nutritional supplement may help reverse this decrease, potentially alleviating intestinal symptoms in patients with the condition.
Researchers from University of South Australia found that porous silica can prevent fats and carbohydrates from being adsorbed in the body. Engineered particles of purified sand are designed to soak up digestive enzymes, fats, and sugars within the gastrointestinal tract.
Scientists discover that increased levels of enzyme alpha 1-6 fucosyltransferase (FUT8) in the colon may lead to ulcerative colitis by altering mucous layer properties, making it more permeable and sticky. Researchers believe this allows bacteria to reach epithelial cells, triggering inflammation.
Researchers found that certain types of dietary fiber cause inflammation in IBD patients, worsening symptoms. A stool test is being developed to predict individual responses to dietary fibers, enabling tailored recommendations.
A study at the University of Helsinki found that periodontitis has a particular link with diabetes and accelerates its progression. The research highlights the importance of considering general and oral health as a whole in healthcare to achieve better treatment outcomes.
A groundbreaking study has determined the threshold for a new measure of early scarring in children with eosinophilic esophagitis, enabling immediate intervention during endoscopy. This allows targeting and reducing treatment time, leading to improvements in symptoms.
A study published in Nature Medicine found that higher levels of microbiota engraftment correlate with better clinical responses to FMT. The research used genomic sequencing and AI to analyze over 1,300 gut samples from donors and patients with various diseases.
A new combination immunotherapy regimen shows remarkable activity in metastatic colorectal cancer patients without liver metastases, achieving a response rate of 40% and median overall survival exceeding 20 months. The study's findings confirm the importance of the tumor microenvironment in shaping the response to immunotherapy.
Researchers found that people with type 2 diabetes are being admitted to hospital at greater frequency for non-traditional complications, including infections and mental health disorders. These emerging complications pose a significant burden on healthcare systems and may require changes to diabetes management.
New research from Flinders University found a molecular link between COVID-19 and serotonin cells in the gut. The study suggests that these cells synthesise and release serotonin, which is highly enriched for SARS-CoV-2 receptors, potentially worsening disease outcomes.
A study published in Frontiers in Immunology found that Japanese herbal medicine DKT reduces colitis severity by preventing gut bacteria loss and increasing immune cells. It restores Lactobacillus levels and promotes type 3 innate lymphoid cells, alleviating inflammatory responses.
The ISM Annual Meeting highlights new topics in oral, vaginal, skin, and gut microbiota, as well as their metabolites and potential implications in diseases like cancer, depression, and stroke. The meeting aims to explore the mechanism behind microbiota efficacy and its potential application in precision medicine.
A new study from Tel Aviv University found that CRISPR therapeutics can lead to a significant loss of genetic material in treated cells, potentially destabilizing the genome and promoting cancer. The researchers detected up to 10% of cells with lost chromosomes, highlighting the need for extra care when using this technology.
A world-first study has confirmed the link between Alzheimer's Disease and multiple gut disorders, revealing shared genetic architecture. The study suggests that abnormal cholesterol levels play a key role in both conditions, and may lead to new potential treatments for Alzheimer's and gut disorders.
Researchers developed an AI system that classifies IBDN lesions accurately, displaying image-based diagnostic ability with 64.5% sensitivity and 89.5% specificity. The correct diagnosis rate of the AI system was 79.0, surpassing that of endoscopists, who achieved a 77.8% accuracy rate.
A team of researchers created an in vitro human model of environmental enteric dysfunction (EED) using the Human Organ Chip technology. The EED Chips recapitulate features of EED found in biopsies from human patients, including inflammation and intestinal barrier dysfunction. The study sheds light on the complex interplay between malnu...
Research on wild Assamese macaques reveals that their gut bacteria composition changes uniquely with age, despite similar lifestyles. This finding suggests that the process is part of natural aging and not due to lifestyle changes, with potential implications for developing personalized therapies against intestinal diseases.
Researchers at Ural Federal University created a sensor to detect human saliva pH levels using a reusable, non-toxic fluorophore. The sensor can pick up small fluctuations in pH and provides accurate results in just 5-7 seconds.
Researchers have found a negative correlation between Helicobacter pylori infection and inflammatory bowel disease (IBD) prevalence, suggesting the bacterium may protect against IBD. This is supported by studies showing improved gut microbiota diversity and increased abundance of beneficial bacteria in H. pylori-infected individuals.
A new preclinical study by Weill Cornell Medicine researchers shows that naturally-produced IgG antibodies in breast milk can protect infants from infection-induced diarrheal illness. These antibodies enhance infant immunity against bacterial pathogens causing gastrointestinal diseases.
A new study found that microgravity analog culture profoundly affects the microbial infection process in 3-D human tissue models. This is critical for ensuring astronaut health on extended space missions and sheds light on mysterious processes of infection on Earth.
Researchers have shown ablation therapy can correct stomach dysrhythmias, eliminating abnormal electrical activity and restoring normal function. The technique may now be able to treat patients suffering from gastrointestinal disorders.
A new study found a bi-directional relationship between gastrointestinal issues and internalized symptoms in children with autism, highlighting the importance of the gut-brain axis. The research aims to develop personalized treatments for individuals with autism experiencing gastrointestinal problems.
Researchers have found that preterm infants with certain viral signatures in their gut are at risk of developing necrotizing enterocolitis (NEC), a serious and often fatal disease. The study highlights the potential for early warning signals to alert clinicians, allowing emergency action to be taken.
A study discovered that a common gut parasite, Blastocystis ST4, has beneficial properties by stabilizing the bacteria ecosystem and promoting quicker recovery from inflammation. The parasite may potentially be translated into probiotics to treat inflammation in patients.
Research reveals that an imbalance in gut microbiota, known as dysbiosis, may contribute to the development and progression of Parkinson's disease. Studies found a direct correlation between gut dysbiosis and Parkinson's, with certain bacteria contributing to protein aggregation and neuronal damage.
A recent report by the International Society of Microbiota confirms a bidirectional interplay between gut microbiota and various organs, highlighting the crucial role of microbiota in disease pathogenesis. The report also explores therapeutic strategies for manipulating gut microbiota to prevent and treat disorders.
Researchers at Penn Medicine have discovered a new approach to treat solid cancers using CDH17CAR T cells, which selectively target and eliminate gastrointestinal (GI) solid tumors like gastric, pancreatic, and colorectal cancers in preclinical models. Unlike other immunotherapies, CDH17CAR T cells do not show toxicity to healthy tissues.
Researchers at Clemson University have identified a genetic variation associated with congenital idiopathic megaesophagus (CIM) in German shepherd dogs, which is often fatal if left untreated. A genetic test using melanin-concentrating hormone receptor 2 and dog's sex can predict the risk of CIM with 75% accuracy.
The SynGAP Research Fund has developed a pre-screening tool to identify potential SYNGAP1 patients through a free online survey. The partnership with Probably Genetic aims to screen undiagnosed patients and provide them with genetic testing resources, ultimately advancing treatment development for SYNGAP1.
Researchers at Karolinska Institutet used spatial transcriptomics to create a map of gene expression in the mouse colon, gaining new insights into inflammatory bowel disease. The study's findings suggest that the colon is divided into more segments than previously thought and could lead to the development of new treatments.
A nationwide study in Germany found that liver cirrhosis has the highest mortality rate among chronic diseases, with 0.94% of hospital admissions affected. The study also showed a decline in mortality rates due to improvements in Hepatitis C treatment, but an increase in non-alcoholic fatty liver disease cases.